XML 94 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Preferred Stock and Stockholders' Equity (Deficit) - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 10, 2020
Feb. 05, 2020
Nov. 11, 2018
Jun. 29, 2016
Dec. 31, 2020
Dec. 31, 2019
Feb. 24, 2021
Feb. 24, 2020
Apr. 26, 2006
Equity [Line Items]                  
Shares of authorized capital stock                 280,000,000
Common stock, shares authorized         250,000,000 250,000,000     250,000,000
Initial Public Offering of Common Stock     $ 0.001   $ 0.001 $ 0.001     $ 0.001
Preferred stock, shares authorized         30,000,000 30,000,000     30,000,000
Issuance of Common Stock to Underwriters         2,814,673        
Net Proceeds from Underwriting         $ 13,016 $ 6,085      
Sale of stock consideration received on transaction         $ 88,661        
Number of securities into which the class of warrant converted     18,939,394            
Warrant Exercise Price per share     $ 2.64            
Warrant exercise, net of commissions and expenses     $ 47,100     $ 52,499      
Common stock, shares outstanding         214,591,906 181,803,320      
Common Stock, shares reserved for future issuance             31,115,329    
Common Stock [Member]                  
Equity [Line Items]                  
Common stock, shares authorized               250,000,000  
Issuance of Common Stock to Underwriters         2,814,673 1,271,274      
Net Proceeds from Underwriting         $ 3 $ 1      
Common stock, shares outstanding             214,667,023 214,667,023  
Common Stock, shares reserved for future issuance               31,115,329  
At The Market Offering [Member]                  
Equity [Line Items]                  
Issuance of Common Stock to Underwriters         2,814,673 1,271,274      
Sale of stock consideration received on transaction         $ 13,000 $ 6,100      
Series 1 Preferred Stock                  
Equity [Line Items]                  
Preferred stock, stated value         $ 1,200 $ 1,200      
Intrexon Corporation/Precigen | Series 1 Preferred Stock                  
Equity [Line Items]                  
Issuance of common stock in licensing agreement (in shares)       100,000 11,415        
Preferred stock, stated value       $ 1,200          
Underwriting Agreement with Jefferies [Member]                  
Equity [Line Items]                  
Issuance of Common Stock to Underwriters 1,284,025 27,826,086              
Underwriters Purchase Price   $ 3.055              
Number of Days Option Exerciable   30 days              
Net Proceeds from Underwriting $ 3,900 $ 84,800              
Underwriting Agreement with Jefferies [Member] | Maximum [Member]                  
Equity [Line Items]                  
Issuance of Common Stock to Underwriters   4,173,912              
Underwriting Agreement [Member]                  
Equity [Line Items]                  
Issuance of Common Stock to Underwriters   27,826,086       1,271,274      
Underwriters Purchase Price   $ 3.055              
Sale of stock consideration received on transaction   $ 84,800     $ 13,000 $ 6,100      
Issuance & sale of common stock in public offering price per share   $ 3.25              
Underwriting Agreement [Member] | Maximum [Member]                  
Equity [Line Items]                  
Issuance of Common Stock to Underwriters   4,173,912              
Underwriters Purchase Price   $ 3.055